Berry Genomics Co.,Ltd (SHE:000710)
China
· Delayed Price · Currency is CNY 14.29
+0.33 (2.36%)
May 14, 2025, 2:45 PM CST
Berry Genomics Co.,Ltd Revenue
In the year 2024, Berry Genomics Co.,Ltd had annual revenue of 1.08B CNY, down -6.36%. Berry Genomics Co.,Ltd had revenue of 217.76M in the quarter ending March 31, 2025, a decrease of -22.08%.
Revenue
1.08B
Revenue Growth
-6.36%
P/S Ratio
4.58
Revenue / Employee
744.59K
Employees
1,448
Market Cap
4.94B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.08B | -73.25M | -6.36% |
| Dec 31, 2023 | 1.15B | -216.59M | -15.83% |
| Jan 1, 2023 | 1.37B | -54.17M | -3.81% |
| Jan 1, 2022 | 1.42B | -118.20M | -7.67% |
| Dec 31, 2020 | 1.54B | -77.26M | -4.78% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 39.59B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Shanghai United Imaging Healthcare | 10.43B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |